Novo Nordisk bought Forma Therapeutics Forma Therapeutics Holdings from 10/14/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Novo Nordisk bought Forma Therapeutics for $1.1 billion, or $20 a share.

Forma Therapeutics Holdings

Review

Source:

{source} pictogram

ir.formatherapeutics.com

Vladimir Petenev

News editor

Write your comment first

News feed

Pfizer reported for 9 months of 2023

10/31/23 PFE

Caterpillar reported for 9 months of 2023

10/31/23 CAT

UTair reported for 9 months of 2023 by RAS

10/31/23 UTAR

Yandex launched a new method of passwordless authorization

10/31/23 YNDX

Rosseti Volga reported for 9 months of 2023 by RAS

10/31/23 MRKV

Detsky Mir recalled the completion of the share acquisition program

10/31/23 DSKY

Yandex launched sales of smart TVs in Belarus

10/31/23 YNDX

Softline will hold an additional share issue in favor of a subsidiary company

10/31/23 SOFL

LFL - sales of Fix Price for 9 months decreased by 5.3%

10/31/23 FIXP

Acron reported for 9 months of 2023 by RAS

10/31/23 AKRN